Difference between revisions of "BioIndustry Association"

From Powerbase
Jump to: navigation, search
(→‎=References)
Line 409: Line 409:
  
 
==Notes==
 
==Notes==
−
Bioindustry Association [http://www.bioindustry.org/cgi-bin/contents_view.pl?SITE_ID=32&ID=94 About Us, Our Mission], accessed March 2007.
 
−
 
  
 
<references/>
 
<references/>

Revision as of 18:21, 31 December 2007

According to its own website:

The BIA exists to promote the human health benefits of new bioscience technologies, encouraging the commercial success of the bioscience industry by focusing on emerging enterprise and the related interests of companies with whom such enterprise trades.
The BIA supports member interests by lobbying Government and Parliament in the UK and Brussels, providing high quality information and business services, and attracting investment from both private and Government sources.[1]

People

Board Members

Corporate Members - from January 2006

Mr Glyn Edwards - Antisoma

Dr Steve Chatfield - Emergent

Dr Andrew Heath - Protherics

Dr Roland Kozlowski - Lectus Therapeutics

Mr Ian Nicholson - Chroma Therapeutics

Mr Peter Nolan - Oxford BioMedica

Dr David Chiswell - Sosei Co. see Sosei Group

Dr Andy Richards - Vectura

Mr Simon Sturge - Vernalis

Dr Jeremy Haigh - Amgen


Associate Members - from January 2006

Ms Kate Bingham - SLV Life Sciences Mr Geoff Newman - InteRea International Mr David Porter - Mizuho

Related people

PR and Lobbying firms

Members at March 2007[1]

Notes

  1. ↑ Bioindustry Association Members Accessed 2007
Retrieved from "https://powerbase.info/index.php?title=BioIndustry_Association&oldid=42299"